Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May;35(3):207-218.
doi: 10.1097/HCO.0000000000000720.

Gut microbiome and cardiovascular disease

Affiliations
Review

Gut microbiome and cardiovascular disease

Yongzhong Zhao et al. Curr Opin Cardiol. 2020 May.

Abstract

Purpose of review: This review aims to highlight the association between gut microbiome and cardiovascular disease (CVD) with emphasis on the possible molecular mechanisms by which how gut microbiome contributes to CVD.

Recent findings: Increasingly, the roles of gut microbiome in cardiovascular health and disease have gained much attention. Most of the investigations focus on how the gut dysbiosis contributes to CVD risk factors and which gut microbial-derived metabolites mediate such effects.

Summary: In this review, we discuss the molecular mechanisms of gut microbiome contributing to CVD, which include gut microbes translocalization to aortic artery because of gut barrier defect to initiate inflammation and microbial-derived metabolites inducing inflammation-signaling pathway and renal insufficiency. Specifically, we categorize beneficial and deleterious microbial-derived metabolites in cardiovascular health. We also summarize recent findings in the gut microbiome modulation of drug efficacy in treatment of CVD and the microbiome mechanisms by which how physical exercise ameliorates cardiovascular health. Gut microbiome has become an essential component of cardiovascular research and a crucial consideration factor in cardiovascular health and disease.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

Z.W. is named as co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics, and have the right to receive royalty payment for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Cleveland Heart Lab or Procter & Gamble. Y.Z. declares no conflict of interest.

Similar articles

Cited by

References

    1. El Kaoutari A, Armougom F, Raoult D, Henrissat B. Gut microbiota and digestion of polysaccharides. Med Sci (Paris). 2014;30:259–65. - PubMed
    1. Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157:121–41. - PMC - PubMed
    1. McCann A, Jeffery IB, Ouliass B, et al. Exploratory analysis of covariation of microbiota-derived vitamin K and cognition in older adults. Am J Clin Nutr. 2019;110:1404–1415.

      * Vitamin K in the form of menaquinone (MK) is synthesized by gut microbes. The total concentrations of MK did not covary with cognition, but certain MK isoforms, particularly the longer chains, are positively associated with cognition.

    1. LeBlanc JG, Milani C, de Giori GS, et al. Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol. 2013;24:160–8. - PubMed
    1. Malago JJ. Contribution of microbiota to the intestinal physicochemical barrier. Benef Microbes. 2015;6:295–311. - PubMed

Publication types